Drug under test brings hope for sickle cell in Africa
A drug, known as hydroxyurea, currently under clinical trials in four African countries may be the panacea for prolonging lives of sickle cell patients, an expert has said. According to…
Opinion: Kenya needs renewable energy not coal
Fossil fuel combustion and especially the burning of coal produces greenhouse gas (GHG) emissions, leading to human induced climate change. Studies indicate that the global average surface temperature is projected…
Replacing old rice varieties
Breeders in Kenya plan to replace rice varieties that farmers have been using for the last three decades. Dr John Kimani, a rice breeder and the Mwea Centre Director at…
ECHO answers unresolved questions but opens Pandora’s box
In culmination of what has been a sore point of speculation for nearly three decades, it is now a matter of scientific evidence that women using the injectable contraceptive Depo-Provera,…
Want to keep fruits fresh? Try these Malian innovations
The sight of rotting mangoes in a few weeks’ time will be awash in the country. Mangoes, a second fruit crop in Kenya, is a seasonal crop with high and…
Millions to suffer from drug resistance globally by 2050
About 700,000 people die annually due to drug resistance globally and the number is expected to increase to 10 million people annually by 2050, a health expert has warned. A…
Cooking gas that comes from human wastes
The increase of informal settlements in Kenya is a stumbling block to achieving universal access to water and proper sanitation by 2030, experts say. According to the Kenya Water for…
Young women’s HIV burden worries experts
As curtains fell on what has been a landmark scientific conference on the prevention, care and treatment of HIV, it was clear that there are many strides made in the…
15 years and counting: Researcher’s relentless charge against HIV
Despite the difference in opinion about the statistics on HIV/AIDS in Nyanza, the concern of scientists in the region is much focused on how best to treat and reduce new…
Stigma and side-effects slowing PrEP adoption
The idea of providing an antiretroviral (ARV) medication as pre-exposure prophylaxis (PrEP) to prevent acquisition of HIV infection by persons at high risk is now well established. However, the full…
